(Q53942673)
Statements
A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 a (Levovist) for Doppler signal enhancement in the portal vascular system. (English)
Gebel M
Caselitz M
Bowen-Davies PE
Weber S
1 August 1998
19
4
148-156